- Home
- CYH vs HUMA Comparison
CYH vs HUMA Comparison
Compare CYH & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYH
- HUMA
- Stock Information
- Founded
- CYH 1985
- HUMA 2004
- Country
- CYH United States
- HUMA United States
- Employees
- CYH N/A
- HUMA N/A
- Industry
- CYH Hospital/Nursing Management
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- CYH Health Care
- HUMA Health Care
- Exchange
- CYH Nasdaq
- HUMA Nasdaq
- Market Cap
- CYH 482.7M
- HUMA 367.6M
- IPO Year
- CYH 1991
- HUMA N/A
- Fundamental
- Price
- CYH $3.59
- HUMA $2.34
- Analyst Decision
- CYH Hold
- HUMA Strong Buy
- Analyst Count
- CYH 8
- HUMA 7
- Target Price
- CYH $4.27
- HUMA $13.00
- AVG Volume (30 Days)
- CYH 2.2M
- HUMA 3.4M
- Earning Date
- CYH 07-23-2025
- HUMA 08-12-2025
- Dividend Yield
- CYH N/A
- HUMA N/A
- EPS Growth
- CYH N/A
- HUMA N/A
- EPS
- CYH N/A
- HUMA N/A
- Revenue
- CYH $12,653,000,000.00
- HUMA $517,000.00
- Revenue This Year
- CYH N/A
- HUMA N/A
- Revenue Next Year
- CYH $3.49
- HUMA $896.45
- P/E Ratio
- CYH N/A
- HUMA N/A
- Revenue Growth
- CYH 1.05
- HUMA N/A
- 52 Week Low
- CYH $2.24
- HUMA $1.15
- 52 Week High
- CYH $6.29
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- CYH 56.80
- HUMA 50.49
- Support Level
- CYH $3.44
- HUMA $2.13
- Resistance Level
- CYH $3.64
- HUMA $2.80
- Average True Range (ATR)
- CYH 0.17
- HUMA 0.18
- MACD
- CYH 0.03
- HUMA 0.01
- Stochastic Oscillator
- CYH 80.95
- HUMA 35.69
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.